Mainz Biomed shares surge 44.13% intraday after showcasing innovative cancer detection solutions at MEDICA 2025.
ByAinvest
Thursday, Nov 13, 2025 12:54 pm ET1min read
MYNZ--
Mainz Biomed surged 44.13% during intraday trading following its announcement to showcase innovative cancer detection solutions at MEDICA 2025. This event highlights the company’s advancements in colorectal and pancreatic cancer screening technologies, including the commercial launch of ColoAlert® in Switzerland and regulatory progress in the UK. Recent developments, such as top-line results from feasibility studies and partnerships with organizations like EDX Medical Group, have reinforced investor confidence in its pipeline. The timing of the MEDICA 2025 announcement aligns with the stock’s sharp intraday rally, signaling renewed market optimism about the company’s diagnostic solutions and growth prospects in oncology.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet